Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Natural plant extracts for treatment of common cold
2005-005207-42Phase 3Completed
- Sponsor
- Procter & Gamble
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in nasopharyngitis and upper respiratory infection (URI) comparing Kan Jang + curcumin, Ibuprofen + chlorphenamine maleate and Placebo (3 arms). Primary endpoint: Patient assessment of severity of the cold (Kan Jang + curcumin vs placebo). Started Dec 2005; status: completed.
02
Drugs
Kan Jang + curcuminibuprofen + chlorphenamine maleate
03
Conditions
nasopharyngitisupper respiratory infection (URI)
Beyond the preview
Go deeper on 2005-005207-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005207-42.